Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and …
Context Accurate staging of high-risk localised, advanced, and metastatic prostate cancer is
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …
Impact of 68Ga-PSMA PET on the management of patients with prostate cancer: a systematic review and meta-analysis
Context 68 Gallium prostate-specific membrane antigen positron emission tomography (68
Ga-PSMA PET) is an emerging imaging modality for assessment of prostate cancer. Recent …
Ga-PSMA PET) is an emerging imaging modality for assessment of prostate cancer. Recent …
Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …
The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study
68Ga-PSMA PET/CT scanning has been shown to be more sensitive than conventional
imaging techniques in patients with prostate cancer. This prospective Australian multicenter …
imaging techniques in patients with prostate cancer. This prospective Australian multicenter …
Metaanalysis of 68Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology
68Ga-PSMA-11 PET is used to stage patients with prostate cancer. We performed an
updated metaanalysis that separates imaging at the time of diagnosis and at the time of …
updated metaanalysis that separates imaging at the time of diagnosis and at the time of …
68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact …
Target volume delineations for prostate cancer (PCa) salvage radiotherapy (SRT) after
radical prostatectomy are usually drawn in the absence of visibly recurrent disease. 68Ga …
radical prostatectomy are usually drawn in the absence of visibly recurrent disease. 68Ga …
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
S Sheikhbahaei, A Afshar-Oromieh, M Eiber… - European journal of …, 2017 - Springer
Background The rapidly expanding clinical adaptation of prostate-specific membrane
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …
[HTML][HTML] 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and …
Context 68 Gallium prostate-specific membrane antigen (PSMA) ligand 68 Ga-HBED-CC-
PSMA (68 Ga-PSMA) is a promising radiotracer for positron emission tomography …
PSMA (68 Ga-PSMA) is a promising radiotracer for positron emission tomography …
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
The oligometastatic state has been proposed as an intermediate stage of cancer spread
between localized disease and widespread metastases. With improvements in diagnostic …
between localized disease and widespread metastases. With improvements in diagnostic …
Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer …
Prostate-specific membrane antigen (PSMA) may be targeted for both diagnostic and
therapeutic purposes in the management of prostate cancer (PCa). In preclinical models …
therapeutic purposes in the management of prostate cancer (PCa). In preclinical models …